Kathleen Mullane to Survival Rate
This is a "connection" page, showing publications Kathleen Mullane has written about Survival Rate.
Connection Strength
0.029
-
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 02; 25(2):369-381.
Score: 0.029